Here are five highlights:
1. The company’s second quarter revenues jumped 3 percent year-over-year to reach $19.1 million.
2. Product revenue was $18.9 million, a 5 percent increase year-over-year. Specifically, in the U.S., product revenue spiked 7 percent year-over-year to $16.4 million.
3. ConforMIS reported a $14.1 million net loss for the quarter, or $0.24 per basic share. This is up from the $12.1 million net loss in the same quarter the year prior.
4. The company’s total gross profit increased to $9.1 million compared to $6.2 million in the second quarter of 2017.
5. As of June 30, ConforMIS’s cash and cash equivalents as well as investments totaled $46.6 million.
To view the full financial report, click here.
More articles on devices and implants:
Globus Medical sales spike 13.8% to $173.4M in Q2: 5 key points
RTI Surgical Q2 revenue shrinks to $70.7M: 5 details
ConforMIS names Carrie Bienkowski to board of directors: 3 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
